0 Bewertungen
ID

42909

Beschreibung

Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Stichworte

Versionen (2)
  1. 26.08.17 26.08.17 -
  2. 17.09.21 17.09.21 -
Rechteinhaber

gsk

Hochgeladen am

17. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    TIME AND EVENTS TABLE Ropinirole Case Report Form GSK RRL100013

    Deutsch Englisch

    TIME AND EVENTS TABLE Ropinirole Case Report Form GSK

    1 Formulare  
    TIME AND EVENTS TABLE
    Beschreibung

    TIME AND EVENTS TABLE

    Assessments
    Beschreibung

    Assessments

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0220825
    IRLSSG diagnostic criteria
    Beschreibung

    IRLSSG diagnostic criteria

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0035258
    UMLS CUI [1,2]
    C2348561
    Inclusion/exclusion criteria
    Beschreibung

    Inclusion/exclusion criteria

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1512693
    UMLS CUI [1,2]
    C0680251
    Subject demography
    Beschreibung

    Subject demography

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0011298
    RLS history
    Beschreibung

    RLS history

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0035258
    Orthostatic blood pressure and heart rate
    Beschreibung

    Orthostatic blood pressure and heart rate

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1095971
    Weight
    Beschreibung

    Weight

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0220825
    Height
    Beschreibung

    Height

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0005890
    ECG
    Beschreibung

    ECG

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0220825
    Medical/surgical history
    Beschreibung

    Medical/surgical history

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0262926
    UMLS CUI [1,2]
    C0455610
    Physical examination
    Beschreibung

    Physical examination

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0031809
    Laboratory evaluation
    Beschreibung

    Laboratory evaluation

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0022885
    Prior/concomitant medication
    Beschreibung

    Prior/concomitant medication

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0013227
    Pregnancy test
    Beschreibung

    Pregnancy test

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0032976
    Dispense Subject Symptom Diary
    Beschreibung

    Dispense Subject Symptom Diary

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2216446
    Dispense Actigraphy device
    Beschreibung

    Dispense Actigraphy device

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1171301
    IRLS Rating Scale
    Beschreibung

    IRLS Rating Scale

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0681889
    CGI Scales (Improvement & Severity)
    Beschreibung

    CGI Scales (Improvement & Severity)

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3639708
    Insomnia Severity Index
    Beschreibung

    Insomnia Severity Index

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0917801
    Written informed consent
    Beschreibung

    Written informed consent

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0021430
    Dispense Patient Global Improvement Scale (PGI) Forms
    Beschreibung

    Dispense Patient Global Improvement Scale (PGI) Forms

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C2986411
    UMLS CUI [1,2]
    C0349674
    Patient satisfaction question
    Beschreibung

    Patient satisfaction question

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3476649
    Quality of Life Questionnaire
    Beschreibung

    Quality of Life Questionnaire

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0451149
    MOS Sleep Scale
    Beschreibung

    MOS Sleep Scale

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3697468
    Profile of Mood States (POMS)
    Beschreibung

    Profile of Mood States (POMS)

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0451394
    Hospital Anxiety and Depression Scale (HADS)
    Beschreibung

    Hospital Anxiety and Depression Scale (HADS)

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C3539657
    Adverse events
    Beschreibung

    Adverse events

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0877248
    Subject randomization
    Beschreibung

    Subject randomization

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0034656
    Pharmacogenomics sample
    Beschreibung

    Pharmacogenomics sample

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1138555
    Study conclusion form
    Beschreibung

    Study conclusion form

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1707478
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    TIME AND EVENTS TABLE Ropinirole Case Report Form GSK

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    TIME AND EVENTS TABLE
    Item
    Assessments
    integer
    C0220825 (UMLS CUI [1])
    Assessments
    Code List
    Assessments
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    IRLSSG diagnostic criteria
    integer
    C0035258 (UMLS CUI [1,1])
    C2348561 (UMLS CUI [1,2])
    Assessments
    Code List
    IRLSSG diagnostic criteria
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Inclusion/exclusion criteria
    integer
    C1512693 (UMLS CUI [1,1])
    C0680251 (UMLS CUI [1,2])
    Assessments
    Code List
    Inclusion/exclusion criteria
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Subject demography
    integer
    C0011298 (UMLS CUI [1])
    Assessments
    Code List
    Subject demography
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    RLS history
    integer
    C0035258 (UMLS CUI [1])
    Assessments
    Code List
    RLS history
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Orthostatic blood pressure and heart rate
    integer
    C1095971 (UMLS CUI [1])
    Assessments
    Code List
    Orthostatic blood pressure and heart rate
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Weight
    integer
    C0220825 (UMLS CUI [1])
    Assessments
    Code List
    Weight
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Height
    integer
    C0005890 (UMLS CUI [1])
    Assessments
    Code List
    Height
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    ECG
    integer
    C0220825 (UMLS CUI [1])
    Assessments
    Code List
    ECG
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Medical/surgical history
    integer
    C0262926 (UMLS CUI [1,1])
    C0455610 (UMLS CUI [1,2])
    Assessments
    Code List
    Medical/surgical history
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Physical examination
    integer
    C0031809 (UMLS CUI [1])
    Assessments
    Code List
    Physical examination
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Laboratory evaluation
    integer
    C0022885 (UMLS CUI [1])
    Assessments
    Code List
    Laboratory evaluation
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Prior/concomitant medication
    integer
    C2347852 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    Assessments
    Code List
    Prior/concomitant medication
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Pregnancy test
    integer
    C0032976 (UMLS CUI [1])
    Assessments
    Code List
    Pregnancy test
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Dispense Subject Symptom Diary
    integer
    C2216446 (UMLS CUI [1])
    Assessments
    Code List
    Dispense Subject Symptom Diary
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Dispense Actigraphy device
    integer
    C1171301 (UMLS CUI [1])
    Assessments
    Code List
    Dispense Actigraphy device
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    IRLS Rating Scale
    integer
    C0681889 (UMLS CUI [1])
    Assessments
    Code List
    IRLS Rating Scale
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    CGI Scales (Improvement & Severity)
    integer
    C3639708 (UMLS CUI [1])
    Assessments
    Code List
    CGI Scales (Improvement & Severity)
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Insomnia Severity Index
    integer
    C0917801 (UMLS CUI [1])
    Assessments
    Code List
    Insomnia Severity Index
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Written informed consent
    integer
    C0021430 (UMLS CUI [1])
    Assessments
    Code List
    Written informed consent
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Dispense Patient Global Improvement Scale (PGI) Forms
    integer
    C2986411 (UMLS CUI [1,1])
    C0349674 (UMLS CUI [1,2])
    Assessments
    Code List
    Dispense Patient Global Improvement Scale (PGI) Forms
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Patient satisfaction question
    integer
    C3476649 (UMLS CUI [1])
    Assessments
    Code List
    Patient satisfaction question
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Quality of Life Questionnaire
    integer
    C0451149 (UMLS CUI [1])
    Assessments
    Code List
    Quality of Life Questionnaire
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    MOS Sleep Scale
    integer
    C3697468 (UMLS CUI [1])
    Assessments
    Code List
    MOS Sleep Scale
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Profile of Mood States (POMS)
    integer
    C0451394 (UMLS CUI [1])
    Assessments
    Code List
    Profile of Mood States (POMS)
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Hospital Anxiety and Depression Scale (HADS)
    integer
    C3539657 (UMLS CUI [1])
    Assessments
    Code List
    Hospital Anxiety and Depression Scale (HADS)
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Adverse events
    integer
    C0877248 (UMLS CUI [1])
    Assessments
    Code List
    Adverse events
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Subject randomization
    integer
    C0034656 (UMLS CUI [1])
    Assessments
    Code List
    Subject randomization
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Pharmacogenomics sample
    integer
    C1138555 (UMLS CUI [1])
    Assessments
    Code List
    Pharmacogenomics sample
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Item
    Study conclusion form
    integer
    C1707478 (UMLS CUI [1])
    Assessments
    Code List
    Study conclusion form
    CL Item
    Screening (1)
    C1409616 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Baseline (2)
    C1442488 (UMLS CUI-1)
    (Comment:en)
    CL Item
    12 Week Double-Blind Treatment Phase (3)
    C0013072 (UMLS CUI-1)
    C0814495 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Early withdrawal (4)
    C2349954 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Follow Up (5)
    C1522577 (UMLS CUI-1)
    (Comment:en)
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video